Affichage 1 à 5 des 5 essais cliniques
|
ESSAI CLINIQUE No essai ClinicalTrials.gov ID |
Coordonnateur(rice) | ||
|---|---|---|---|
|
(EN) A Phase 1/2 Study of CPI-0610, a Small Molecule Inhibitor of BET Proteins: Phase 1 (in Patients With Hematological Malignancies) and Phase 2 (Dose Expansion of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosis)
CPI-0610-02 NCT02158858  Actif en recrutement
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL
HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS
|
Syndrome myélodysplasique |
Chadi Zakaria 514-340-8222 |
|
(EN) Registre Canadien de la SMD
Registre SMD Actif en recrutement
|
HOPITAL DE L'ENFANT-JESUS
|
Syndrome myélodysplasique |
Linda Vallée 418-649-0252 poste 66602 |
|
(EN) A Randomized, Double-blind, Placebo-controlled Phase II Multi-center Study of Intravenous MBG453 Added to Hypomethylating Agents in Adult Subjects With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS) as Per IPSS-R Criteria
CMBG453B12201 NCT03946670 Actif en recrutement
|
CHU DE QUEBEC – UNIVERSITE LAVAL
HOPITAL DE L'ENFANT-JESUS
|
Syndrome myélodysplasique |
Marie-Claude Lépine 418-649-0252 poste 63401 |
|
(EN) A Study to Evaluate Imetelstat (GRN163L) in Transfusion-Dependent Subjects With IPSS Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) That is Relapsed/Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment
CR107947 NCT02598661 Actif en recrutement
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL
HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS
|
Syndrome myélodysplasique |
Erika Thibault 514-340-8222 |
|
Registre de l’hémoglobinurie paroxystique nocturne (HPN)
Registre PNH (M07-001) NCT01374360 Actif en recrutement
|
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL
PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX
|
Syndrome myélodysplasique |
Johanne Blais 514-252-3400 poste 3295 |
Groupe d'étude en oncologie du Québec